3648 results for «2543»
3648 results
Managing life-threatening TAVI complications
19 May 2026 – From EuroPCR 2026
Manage life-threatening complications in TAVI procedures with a structured algorithm for identification and resolution. This session shares expert tips for handling specific severe complications and reviews best practices aimed at complication avoidance to enhance patient safety and procedural success.
All we need to know about vulnerable plaque
19 May 2026 – From EuroPCR 2026
Understand the critical importance of vulnerable plaque identification and management. This session covers optimal strategies for detecting vulnerable plaques, their prognostic implications, and evidence-based treatment approaches illustrated through detailed case presentations.
Next generation TAVI procedural planning
19 May 2026 – From EuroPCR 2026
Explore the forefront of TAVI procedural planning, featuring innovations such as valve-in-valve techniques for sutureless valves, integration of artificial intelligence in heart team decisions, and advanced imaging-guided access methods. The session also examines clinical outcomes related to bicuspid anatomy and prosthesis-patient mismatch, providing a comprehensive view...
Selecting PCI devices in specific scenarios
19 May 2026 – From EuroPCR 2026
This session addresses device selection strategies tailored to specific interventional cardiology scenarios. It covers innovative approaches such as coronary laser use in difficult lesions, intravascular imaging-guided treatments for in-stent restenosis, and physiological assessment post-magnesium scaffold resorption, supported by real-world data and emerging machine learning applications.
New evidence in the treatment of calcified lesions
19 May 2026 – From EuroPCR 2026
This session presents the latest evidence on treating calcified coronary lesions, comparing intravascular lithotripsy, cutting balloons, rotational and orbital atherectomy. It includes clinical trial data on efficacy, safety, and impact on coronary microvascular function, providing a robust foundation for evidence-based decision-making in calcified lesion management.
TAVI procedural complications - Part 1: VSD, valve embolisation, and more
19 May 2026 – From EuroPCR 2026
This session focuses on the complex complications that can arise during TAVI procedures, such as ventricular septal defects, valve embolisation, and other critical events. Through detailed case analyses, it offers strategies for recognition, prevention, and management to improve patient safety and outcomes.
How to prevent and manage complex and complicated LAA closure cases?
19 May 2026 – From EuroPCR 2026
Designed to enhance procedural success in transcatheter left atrial appendage closure, this session addresses identification of complex anatomies, management of intraprocedural challenges, and strategies to prevent and handle complications, illustrated by practical case examples and expert evaluations.
Evidence for new devices in management of coronary artery disease
19 May 2026 – From EuroPCR 2026
This session reviews the latest evidence on new devices in coronary artery disease management. It covers outcomes from randomized controlled trials including imaging- and physiology-guided PCI with the Bioadaptor device, long-term results of thinner-strut bioresorbable scaffolds, site-specific antithrombotic therapy evaluated in the DESyne BDS Plus Trial,...
How should I treat a patient with a calcified mitral anatomy?
19 May 2026 – From EuroPCR 2026
This session explores the management of patients with calcified mitral anatomy, from advanced imaging assessment to intervention planning. It evaluates the suitability of mitral annular calcification for transcatheter edge-to-edge repair (TEER) and discusses alternative therapeutic options for patients ineligible for TEER.
Clinical cases - Nurses and Allied Professionals
19 May 2026 – From EuroPCR 2026
Dedicated to nurses and allied health professionals, this session presents compelling clinical cases illustrating their critical role in interventional cardiology. Topics range from managing pregnant patients in the cath lab, the impactful contributions of nursing and allied professionals (NAPs), to their management perspectives during complex procedures...
Angiography-based physiology in clinical practice
19 May 2026 – From EuroPCR 2026
Investigate the clinical application of angiography-based physiology in coronary artery disease management. This session covers quantitative flow ratio (QFR) guided PCI strategies, risk stratification in chronic coronary syndrome, and prognostic value of angiography-derived indices, offering a wire-free diagnostic approach supported by recent trial data.
Clinical experience with transcatheter tricuspid valve replacement
19 May 2026 – From EuroPCR 2026
This session shares clinical experience with transcatheter tricuspid valve replacement (TTVR) for severe tricuspid regurgitation. It includes outcomes after prior repair, analysis of stent frame geometry as a predictor of leaflet abnormalities, and assessments of functional and quality-of-life improvements with systems such as Evoque and MonarQ....
Optimal management of primary PCI complications
19 May 2026 – From EuroPCR 2026
This session delves into the optimal management of complications arising during primary PCI. It addresses critical scenarios from initial hesitation and unexpected challenges to confident treatment strategies for vessel complications. Notably, it explores complex cases such as paradoxical embolisation following rescue PCI in STEMI patients, providing...
PCR's Got Talent Round 1 - Session 1
19 May 2026 – From EuroPCR 2026
This dynamic session from PCR's Got Talent Round 1 presents a diverse array of cutting-edge research and clinical findings. Topics include the influence of local and systemic inflammation on PCI outcomes, adherence to OCT-guided PCI metrics, comparative guidance strategies using angiography-derived FFR and IVUS, and the...
Risk stratification and drug therapies in coronary arteries interventions
19 May 2026 – From EuroPCR 2026
This session offers a detailed examination of risk stratification and pharmacologic therapies in coronary artery interventions. It features innovative markers such as left ventricle filling pressure (E/E' ratio) for predicting myocardial injury, clinical outcome impacts in dialysis-dependent patients, intraoperative DOAC removal during CABG, and machine learning...
From left to right: different perspectives on heart failure management
19 May 2026 – From EuroPCR 2026
Exploring diverse perspectives on heart failure management, this session presents a range of complex clinical cases. Topics include facilitated treatment of post-myocardial infarction interventricular septal defects, left ventricular perforation following Impella placement, diagnostic challenges in shock scenarios, the implications of severe right ventricular dysfunction on left...
Value of imaging for treatment of calcified lesions
19 May 2026 – From EuroPCR 2026
This session highlights the critical value of imaging in the treatment of calcified coronary lesions. It reviews techniques for lesion modification, including innovative balloon-based strategies and multimodality approaches for balloon-uncrossable calcified left main bifurcations. The session also discusses the tactical cracking of calcified plaques and strategies...
Best clinical CTO cases
19 May 2026 – From EuroPCR 2026
This session presents exemplary clinical cases in chronic total occlusion (CTO) PCI, illustrating advanced procedural strategies and complication management. Cases include retrograde CTO-PCI complicated by catheter-induced dissection, expansion of antegrade CTO PCI limits with hybrid approaches, successful combined antegrade and retrograde hydrodynamic contrast recanalisation, and staged...
Innovations in vascular therapies
19 May 2026 – From EuroPCR 2026
Discover cutting-edge innovations in vascular therapies highlighting novel technologies such as Pulse Intravascular Lithotripsy (IVL) for calcium modification and Amplitude Vascular Systems. The session also presents drug-free restenosis control strategies via CD31 camouflage coating promoting physiological-grade healing, emphasizing emerging solutions aimed at improving vascular intervention outcomes.
Aortic paravalvular leak unmasked: different faces, different strategies
19 May 2026 – From EuroPCR 2026
Examine diverse clinical scenarios and management strategies for aortic paravalvular leaks (PVL), including complex percutaneous closures post-TAVI and surgical interventions. This session presents challenging cases demonstrating varied presentations and approaches such as mechanical valve loop utilization, highlighting the complexities and tailored solutions required for successful PVL...